In the days of the Armada, a fleet of warships, the scuttlebutt was the rumor or gossip that would spread throughout the ship. Today, Armada Law Corp presents The Scuttlebutt, a daily summery of news articles that people within the cannabis, hemp and plant medicine industries are chatting about along with links to the full articles.
In today’s news:
However, new research
suggests that although it may be relatively safe to use serotonergic antidepressants in pre-treatment time for patients with psychiatric disorders, SSRIs and SNRIs may diminish psilocybin’s effects, and the dampening effect can be observed for up to 3 months after stopping the antidepressant medication.”
#cannabisindustry – “With more than $10 million in retail sales during its opening weekend and more than $20 million in retail sales during the first week, Maryland’s adult-use cannabis market is open for business. Nearly 100 of Maryland’s existing medical cannabis dispensaries and 42 cultivators and manufacturers converted their licenses to now serve both medical patients and adult consumers, but this is just the beginning and new licenses are about to be available.”